BELSOMRA suvorexant 20mg tablet blister pack

Merck Sharp & Dohme (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 52f1e445c844e8e3
Product Name: BELSOMRA suvorexant 20mg tablet blister pack
Artg Id: 207712
Artg Name: BELSOMRA suvorexant 20mg tablet blister pack
Sponsor: Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path: /organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date: 2016-11-16
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/063c781aa010f151e03115dd000d3db3.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/3cbb7636ab98b6cf84af56c0ed839a32.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

52f1e445c844e8e3

Type

Standard